Gates Foundation Launches Nonprofit Biotech Research Institute To Focus On Malaria, TB, Enteric Diseases
Forbes: Bill And Melinda Gates Start A Nonprofit Biotech In Boston
“…The Bill & Melinda Gates Medical Research Institute … will aim to develop new medicines and vaccines for malaria, tuberculosis, and diarrhea, which together account for 2.6 million deaths a year globally, many of them in children…” (Harper, 6/7).
STAT: The Gates Foundation rolls outs details of its new biotech, one without a profit motive
“…The Bill & Melinda Gates Foundation has spun out a nonprofit biotech offspring, the Bill & Melinda Gates Medical Research Institute. With funding of $273 million for its first four years, the organization is in an enviable position. ‘We don’t have to worry about revenue, return on investment. Our bottom line is lives saved. So it’s a pretty exciting place to be,’ Dr. Penny Heaton, the institute’s CEO, explained in an interview with STAT this week…” (Branswell, 6/7).
The KFF Daily Global Health Policy Report summarized news and information on global health policy from hundreds of sources, from May 2009 through December 2020. All summaries are archived and available via search.